Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

239 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Completed

A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer

NCT03809013

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Anhui Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
View Trial Details
Completed

Derazantinib and Atezolizumab in Patients With Urothelial Cancer

NCT04045613

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +26 more
Locations
  • CTCA Clinical Research Inc., Atlanta Newnan, Georgia, United States
  • Englander Institute Weill Cornell Medicine New York, United States
  • New York Cancer and Blood Specialists Port Jefferson Station, New York, United States
  • University of Texas Southwestern Medical Center (UTSWMC) Dallas, Texas, United States
View all 66 locations
View Trial Details
Completed

UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch

NCT02643043

Conditions
Bladder Cancer, Cancer of the Ureter, Carcinoma, +20 more
Locations
  • University of Southern Cailfornia Los Angeles, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Ichan School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

A Study of a Personalized Neoantigen Cancer Vaccine

NCT03639714

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer

NCT02426125

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +15 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • St. Jude Medical Center Fullerton, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
View all 141 locations
View Trial Details
Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

NCT03636256

Conditions
Bladder Cancer, Cancer of the Bladder, Carcinoma, +20 more
Locations
  • BCG Oncology, PC Phoenix, Arizona, United States
  • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, Maryland, United States
  • Columbia University Herbert Irving Comprehensive Cancer Center New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details
Completed

A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

NCT04452214

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +28 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Hospital of The University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions